Objectives: Interest in the intravesical instillation of capsaicin is growi
ng among urologists. Its efficacy on detrusor hyperreflexia, hypersensitive
bladder disorders and bladder pain has been reported in several studies. H
owever, the lack of common evaluation parameters and the absence of consens
us concerning a protocol of instillation hamper the interpretation of resul
ts. The purpose of this review is to better delineate the indications and o
ptimum protocol for intravesical use of capsaicin. Methods: Eight open and
two placebo-controlled human clinical trials were analyzed. All 200 patient
s involved had lower urinary tract disorders. Results: Clinical or urodynam
ic symptoms improved in 84.3% of the patients who received intravesical cap
saicin for neurogenic hyperreflexic bladder, a significantly greater effica
cy than that of placebo, Capsaicin may also be beneficial in patients who h
ave non-neurogenic disorders, Whether or not the patients has a neurologic
deficit, side effects appear during and in the period immediately following
instillation. Conclusions: Intravesical capsaicin appears to be indicated
in neurogenic hyperreflexic bladder, but is less effective against detrusor
instability, hypersensitive bladder disorders or pelvic pain, The best ins
tillation protocol and long-term tolerance remain to be established.